Supriya Lifescience Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 168.62 | 162.85 | 160.37 |
| Operating Expense | 101.39 | 98.09 | 102.68 |
| Net Profit | 46.15 | 44.64 | 36.93 |
| Net Profit Margin | 27.37 | 27.41 | 23.03 |
| Earning Per Share | 5.71 | 5.54 | 4.59 |
| EBIDTA | 66.77 | 64.31 | 50.38 |
| Effective Tax Rate | 22.98 | 22.65 | 15.50 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 168.62 |
| Operating Expense | 101.39 |
| Net Profit | 46.15 |
| Net Profit Margin | 27.37 |
| Earning Per Share | 5.71 |
| EBIDTA | 66.77 |
| Effective Tax Rate | 22.98 |
Invest in Supriya Lifescience Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 570.37 | 460.94 | 530.05 |
| Operating Expenses Annual | 397.39 | 332.04 | 316.06 |
| Operating Profit Annual | 183.61 | 138.39 | 221.56 |
| Interest Annual | 2.11 | 3.08 | 4.20 |
| Depreciation | 15.81 | 11.82 | 10.12 |
| Net Profit Annual | 119.11 | 89.86 | 151.81 |
| Tax Annual | 46.58 | 33.63 | 55.44 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 570.37 |
| Operating Expenses Annual | 397.39 |
| Operating Profit Annual | 183.61 |
| Interest Annual | 2.11 |
| Depreciation | 15.81 |
| Net Profit Annual | 119.11 |
| Tax Annual | 46.58 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 157.58 | 227.91 | 89.28 |
| Cash Flow from Operations | 113.31 | 63.61 | 48.80 |
| Cash Flow from Investing | -173.58 | -123.65 | -59.82 |
| Cash Flow from Financing | -22.36 | -10.28 | 149.65 |
| Cash Flow at the End | 74.96 | 157.58 | 227.91 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 157.58 |
| Cash Flow from Operations | 113.31 |
| Cash Flow from Investing | -173.58 |
| Cash Flow from Financing | -22.36 |
| Cash Flow at the End | 74.96 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 28.85 | 26.79 | 37.65 |
| PBIT Margin (%) | 26.41 | 24.50 | 35.93 |
| PBT Margin (%) | 21.28 | 16.54 | 27.37 |
| Net PROFIT Margin (%) | 18.41 | 17.40 | 25.80 |
| Return On Networth / Equity (%) | 15.73 | 13.67 | 34.34 |
| Return On Networth /Employed (%) | 22.05 | 18.43 | 41.97 |
| Return On Assets (%) | 15.47 | 13.05 | 30.18 |
| Total Debt / Equity (X) | 0.02 | 0.04 | 0.11 |
| Asset Turnover Ratio (%) | 0.84 | 0.75 | 1.17 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 28.85 |
| PBIT Margin (%) | 26.41 |
| PBT Margin (%) | 21.28 |
| Net PROFIT Margin (%) | 18.41 |
| Return On Networth / Equity (%) | 15.73 |
| Return On Networth /Employed (%) | 22.05 |
| Return On Assets (%) | 15.47 |
| Total Debt / Equity (X) | 0.02 |
| Asset Turnover Ratio (%) | 0.84 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 310.13 | 261.54 | 189.77 |
| Total Current Assets Annual | 397.81 | 464.89 | 497.54 |
| Non Current Assets Annual | 523.43 | 355.39 | 237.22 |
| Total Shareholders Funds Annual | 815.37 | 699.46 | 615.69 |
| Total Assets Annual | 921.24 | 820.28 | 734.76 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 310.13 |
| Total Current Assets Annual | 397.81 |
| Non Current Assets Annual | 523.43 |
| Total Shareholders Funds Annual | 815.37 |
| Total Assets Annual | 921.24 |
No Data Availabe
